NAIROBI, Kenya – The Kenya Medical Supplies Authority (KEMSA) is introducing a digital tracking system designed to make it harder for medicines intended for public hospitals to be stolen, diverted or delivered to unauthorised destinations.
The system will allow medical supplies to be monitored from manufacturers through warehouses and distribution networks to health facilities and, ultimately, patients.
KEMSA Chief Executive Officer Waqo Ejersa said the technology would strengthen accountability by enabling officials to trace individual medicine packs and identify unexplained movements across the supply chain.
“This technology is a game changer in the management of medical supplies. It will ensure every product can be tracked from the manufacturer to the final patient, strengthening accountability across the supply chain,” Ejersa said.
The initiative is being implemented in partnership with the Ministry of Health and will use GS1 DataMatrix barcodes to give each product a traceable identity.
Unlike conventional stock records that may account for medicines in bulk, the system will capture details at individual pack level, including product identification, manufacturing batch, expiry date and a unique serial number.
This will allow KEMSA to establish where specific products originated, where they were delivered and at what point discrepancies may have occurred.
KEMSA will also integrate the tracking technology with its Enterprise Resource Planning (ERP) platform and the National Logistics Management Information System to improve stock visibility and coordination.
Additional safeguards will include geo-fenced electronic locks for selected consignments and electronic proof-of-delivery systems. These are intended to help officials monitor medical supplies while in transit and verify that deliveries reach their designated facilities.
New Rules Set Stage for Individual Medicine Tracking in 2027
The rollout comes ahead of a December 31, 2026 deadline requiring pharmaceutical manufacturers and suppliers working with KEMSA to comply with internationally recognised GS1 identification standards.
From January 1, 2027, individual medicine packs are expected to undergo serialisation, with each pack assigned a unique identification number.
This will allow officials to trace specific products independently, check their distribution history and identify batches that may have been misplaced, diverted or flagged for further investigation.
The reforms also support efforts to identify affected batches when medicine safety concerns arise, making it easier to trace products and take appropriate action.
KEMSA Reports Improvement in Medicine Supply
The authority says its order fill rate has risen to 92 per cent, up from 40 per cent in 2022.
Its funding has also increased from Sh5 billion to Sh21 billion, according to the figures provided by the authority.
The digital tracking system is expected to strengthen oversight as KEMSA distributes essential medical commodities to public health facilities across the country.




